Pulmonology
From the Journals
Immunotherapy and Survival in Advanced NSCLC: Does Obesity Matter?
Researchers evaluated 31,257 patients with advanced NSCLC from Japan who received immune checkpoint inhibitors or conventional chemotherapy.
From the Journals
Cannabis Overuse Linked to Increased Risk for Head and Neck Cancer
Researchers analyzed data of 116,000 individuals with cannabis-related disorder.
Latest News
How Safe is Anti–IL-6 Therapy During Pregnancy?
Transient neonatal cytopenia was the only possible adverse outcome that could be related to anti–IL-6 therapy.
From the Journals
PPI Prophylaxis Prevents GI Bleed in Ventilated Patients
Recent guidelines have issued only weak recommendations for stress ulcer prophylaxis, especially with PPIs, in critically ill patients at a high...
From the Journals
Can Addressing Depression Reduce Chemo Toxicity in Older Adults?
Researchers evaluated whether greater reductions in grade 3 chemotherapy-related toxicities occurred with geriatric assessment-driven...
Latest News
Few Smokers Who Want to Quit Seek Healthcare Provider Help
Previous research has shown that clinician intervention and evidence-based treatment increase the odds that smokers can quit successfully.
Latest News
Air Pollution and Genetics May Raise Risk for Lupus
Those reguarly exposed to fine particulate matter air pollution, and with genetic risk, may have increased SLE risk.
Latest News
Ozempic Curbs Hunger – And Not Just for Food
Ozempic may be effective to help “overconsumption” of alcohol, cannabis, cigarettes, suggests research.
Latest News
Vasculopathy Can Vary in Patients With Idiopathic Pulmonary Arterial Hypertension
More research is needed to better define IPAH with nonplexiform vasculopathy and to identify causes and treatment.
News
Are Beta-Blockers Safe for COPD?
A COPD with comorbid CV disease RCT is unlikely, says physician, though benefit of stopping beta-blockers is unclear.
Latest News
More Illnesses Possible Related Linked to Counterfeit Botulinum Toxin Reported
This report follows a CDC advisory published in April 2024 of at least 22 people from 11 states who reported serious reactions after receiving...